Last reviewed · How we verify
NCT04268615: CS-TRIGGER
Covert Saccade Triggers in Bilateral Vestibular Hypofunction
NA trial testing Covert Saccades and Virtual Reality in Reflex, Abnormal in 32 participants. Completed in 21 March 2022.
21 March 2022
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 32 |
| Start date | 15 December 2020 |
| Primary completion | 21 March 2022 |
| Estimated completion | 21 March 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Covert Saccades and Virtual Reality
- Actives versus passives Head Impulses
- Visually guided saccades
Conditions studied
- Reflex, Abnormal — all drugs for Reflex, Abnormal →
- Bilateral Vestibulopathy — all drugs for Bilateral Vestibulopathy →
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
Adults 18 to 90, any sex, with Reflex, Abnormal or Bilateral Vestibulopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with chronic bilateral vestibular hypofunction may suffer from a visual instability during head movement called oscillopsia. Visual consequence of vestibular deficit can lead to a severe impairment of their quality of life. However, correcting saccades during rapid head movement, called covert-saccades, have been more recently identified. These saccades, which occur during the head movement in patients with vestibular hypofunction, present a very short latency. They could compensate for the lack of vestibular-ocular reflex and greatly decrease oscillopsia and visual impairment. The triggering of these covert-saccade is still not known. They could be of visual origin but the short latency is unusual. The objective of this study is to evaluate the potential role of visual trigger in 12 patients with chronic bilateral areflexia, using different visuo-vestibular conditions. The latency of simple visually guided saccades will also be tested in the group of patients and a group of 12 healthy controls.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Virtual reality set-up for studying vestibular function during head impulse test.
Desoche C, Verdelet G, Salemme R, Farnè A, et al · · 2023 · cited 4× · PMID 37064179 · DOI 10.3389/fneur.2023.1151515
Verify or expand the search:
- PubMed search for NCT04268615
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04268615 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 2 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04268615.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing